Association of metabolic and genetic factors with cholesterol esterification rate in HDL plasma and atherogenic index of plasma in a 40 years old Slovak population

Physiological Research

Volumn 60, Issue 5, 2011, Pages 785-795

  Raslova K ^a   Dobiasova M ^b   Hubacek J A ^c,d   Bencova D ^e   Sivakova D ^e   Dankova Z ^e   Franekova J ^c   Jabor, A ^c   Gasparovic J ^a   Vohnout, B ^a  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

^e Faculty of Natural Sciences   (Slovakia)

Author keywords

Atherogenic index of plasma (AIP); Biomarkers of CVD; Cilp2; Fto; Mlxipl

Indexed keywords

EID: 84856451445     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.932069     Document Type: Article

References (28)

1. AUSTIN MA, BRUNZELL JD, FITCH WL, KRAUSS RM. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 10: 520-530, 1990.
2. BITTNER V, JOHNSON BD, ZINEH I, ROGERS WJ, VIDO D, MARROQUIN OC, BAIREY-MERZ CN, SOPKO G The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE). Am Heart J 157: 548-555, 2009.
3. BROWN BG, ZHAO XQ, CHAIT A, FISHER LD, CHEUNG MC, MORSE JS, DOWDY AA, MARINO EK, BOLSON EL, ALAUPOVIC P, FROHLICH J, ALBERS JJ: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345: 1583-1592, 2001.
4. DAY IN, HUMPHRIES SE Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal Biochem 222: 389-395, 1994.
5. DE BACKER G, AMBROSIONI E, BORCH-JOHNSEN K, BROTONS C, CIFKOVA R, DALLONGEVILLE J, EBRAHIM S, FAERGEMAN O, GRAHAM I, MANCIA G, CATS VM, ORTH-GOMÉR K, PERK J, PYÖRÄLÄ K, RODICIO JL, SANS S, SANSOY V, SECHTEM U, SILBER S, THOMSEN T, WOOD D EUROPEAN SOCIETY OF CARDIOLOGY COMMITTEE FOR PRACTICE GUIDELINES: European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 10: S1-S10, 2003.
6. DOBIÁŠOVÁ M, FROHLICH J, ŠEDOVÁ M, CHEUNG MC, BROWN BG Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res 52: 566-571, 2011.
7. DOBIÁŠOVÁ M, FROHLICH J The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL). Clin Biochem 34: 583-588, 2001.
8. DOBIÁŠOVÁ M, FROHLICH J Measurement of fractional esterification rate of cholesterol in plasma depleted of apoprotein B containing lipoprotein: methods and normal values. Physiol Res 45: 65-73, 1996.
9. HDL) and logarithmically transformed ratio of triglycerides to HDL-cholesterol. Physiol Res 50: 1-8, 2001.
10. DOBIÁŠOVÁ M, URBANOVÁ Z, ŠAMÁNEK M Relations between particle size of HDL and LDL lipoproteins and cholesterol esterification rate. Physiol Res 54: 159-165, 2005.
11. DOBIÁŠOVÁ M Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications. Clin Chem 50: 1113-1115, 2004.
12. DREXEL H, AMAN FW, RENTSCH K, NEUNSCHWANDER C, LEUTHY A, KHAN SI, FOLLATH F Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol 70: 436-440, 1992.
13. FROHLICH J, DOBIÁŠOVÁ M Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem 49: 1873-1880, 2003.
14. GAŠPAROVIČ J, BAŠISTOVÁ Z, FÁBRYOVÁ L, WSÓLOVÁ L, VOHNOUT B, RAŠLOVÁ K; SLOVAK MED PED FH GROUP: Familial defective apolipoprotein B-100 in Slovakia: Are differences in prevalence of familial defective apolipoprotein B-100 explained by ethnicity? Atherosclerosis 194: e95-e107, 2007
15. GENEST J: The Yin and Yang of high-density lipoprotein cholesterol. J Am Coll Cardiol 51: 643-644, 2008.
16. GOESSLING W, MASSARO JM, VASAN RS, D'AGOSTINO RB Sr, ELLISON RC, FOX CS: Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 135: 1935-1944, 2008.
17. GRUNDY SM Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy. Am J Cardiol 75 (Suppl): 45B-52B, 1995.
18. HUBÁČEK JA, PIŤHA J, ADAMKOVA V, LANSKA V, POLEDNE R A common variant in the FTO gene is associated with body mass index in males and postmenopausal females but not in premenopausal females. Czech post-MONICA and 3PMFs studies. Clin Chem Lab Med 47: 387-390, 2009.
19. KATHIRESAN S, MELANDER O, GUIDUCCI C, SURTI A, BURTT NP, RIEDER MJ, COOPER GM, ROOS C, VOIGHT BF, HAVULINNA AS, WAHLSTRAND B, HEDNER T, CORELLA D, TAI ES, ORDOVAS JM, BERGLUND G, VARTIAINEN E, JOUSILAHTI P, HEDBLAD B, TASKINEN MR, NEWTON-CHEH C, SALOMAA V, PELTONEN L, GROOP L, ALTSHULER DM, ORHO-MELANDER M Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40: 189-197, 2008.
20. MCLAUGHLIN T, REAVEN G, ABBASI F, LAMENDOLA C, SAAD M, WATERS D, SIMON J, KRAUSS RM Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 96: 399-404, 2005
21. MÜLLER-NORDHORN J, BINTING S, ROLL S, WILLICH SN: An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 29: 1316-1326, 2008.
22. NAKAYAMA K, BAYASGALAN T, YAMANAKA K, KUMADA M, GOTOH T, UTSUMI N, YANAGISAWA Y, OKAYAMA M, KAJII E, ISHIBASHI S, IWAMOTO S JICHI COMMUNITY GENETICS TEAM (JCOG): Large scale replication analysis of loci associated with lipid concentrations in a Japanese population. J Med Genet 46: 370-374, 2009.
23. SCUTERI A, SANNA S, CHEN WM, UDA M, ALBAI G, STRAIT J, NAJJAR S, NAGARAJA R, ORRÚ M, USALA G, DEI M, LAI S, MASCHIO A, BUSONERO F, MULAS A, EHRET GB, FINK AA, WEDER AB, COOPER RS, GALAN P, CHAKRAVARTI A, SCHLESSINGER D, CAO A, LAKATTA E, ABECASIS GR: Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 3: e115, 2007.
24. TAI ES, SIM XL, ONG TH, WONG TY, SAW SM, AUNG T, KATHIRESAN S, ORHO-MELANDER M, ORDOVAS JM, TAN JT, SEIELSTAD M: Polymorphisms at newly identified lipid-associated loci are associated with blood lipids and cardiovascular disease in an Asian Malay population. J Lipid Res 50: 514-520, 2009.
25. TAN MH, JOHNS D, GLAZER NB Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin Chem 50: 1184-1188, 2004.
26. TAN MH, LOH KC, DOBIASOVA M, FROHLICH JJ Fractional esterification rate of HDL particles in patients with type 2 diabetes. Relation to coronary heart disease risk factors. Diabetes Care 21: 139-142, 1998.
27. VRÁBLIK M, ČEŠKA R, ADAMKOVA V, PEASEY A, PIKHART H, KUBINOVA R, MARMOT M, BOBAK M, HUBACEK JA MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe. Hum Genet 124: 553-555, 2008.
28. YILMAZ Y: Liver function tests: Association with cardiovascular outcomes. World J Hepatol 2: 143-145, 2010. www.biomed.cas.cz/fgu/aip AIP calculator.